The effects of cations on the inhibition of sodium and potassium activated adenosinetriphosphatase by beryllium.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000641:Ammonia / Q000494:pharmacology; D000818:Animals; D001608:Beryllium / Q000494:pharmacology*; D002118:Calcium / Q000494:pharmacology; D006168:Guinea Pigs; D007668:Kidney / Q000201:enzymology; D008094:Lithium / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D012413:Rubidium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology
D008345:Manganese; D010042:Ouabain; D000641:Ammonia; D008094:Lithium; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D012413:Rubidium; D001608:Beryllium; D011188:Potassium; D002118:Calcium